Applied Genetic Technologies Corp. Company Profile (NASDAQ:AGTC)

Analyst Ratings

Consensus Ratings for Applied Genetic Technologies Corp. (NASDAQ:AGTC) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $29.14 (85.74% upside)

Analysts' Ratings History for Applied Genetic Technologies Corp. (NASDAQ:AGTC)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Cantor FitzgeraldReiterated RatingBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016WedbushReiterated RatingOutperform$36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/25/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/11/2016BMO Capital MarketsInitiated CoverageOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Janney Montgomery ScottInitiated CoverageBuy$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Stifel NicolausLower Price TargetBuy$32.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/10/2016Chardan CapitalReiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/3/2014WunderlichReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Applied Genetic Technologies Corp. (NASDAQ:AGTC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
9/8/2016        
5/9/2016Q3$0.05$0.11$12.98 million$12.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2016Q216($0.19)$0.17$8.76 million$12.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q1($0.19)($0.53)$5.91 million$11.06 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/10/2015Q415($0.41)($0.48)$0.71 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q315($0.33)($0.38)$0.59 million$0.28 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2015Q215($0.39)($0.28)$0.65 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2014Q115($0.29)($0.34)$258.00 million$705.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
9/26/2014Q414($0.35)($0.32)$0.12 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2014Q114($0.37)($25.45)$0.15 million$0.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Applied Genetic Technologies Corp. (NASDAQ:AGTC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20162($0.02)$0.00($0.01)
Q1 20171($0.09)($0.09)($0.09)
Q2 20171($0.13)($0.13)($0.13)
Q3 20171($0.03)($0.03)($0.03)
Q4 20171($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Applied Genetic Technologies Corp. (NASDAQ:AGTC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Applied Genetic Technologies Corp. (NASDAQ:AGTC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/23/2015Plc GlaxosmithklineMajor ShareholderSell503,150$22.00$11,069,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/23/2015Daniel L MenichellaVPSell1,996$24.90$49,700.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014Daniel L MenichellaVPSell9,000$20.83$187,470.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Interwest Partners Viii LpMajor ShareholderBuy75,376$12.00$904,512.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Jill CarrollDirectorBuy103,762$12.00$1,245,144.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Applied Genetic Technologies Corp. (NASDAQ:AGTC)
DateHeadline
07/22/16 02:21 PMApplied Genetic Technologies Corporation (NASDAQ:AGTC) Stock Technicals Hit Strength - CML News
07/22/16 10:34 AMApplied Genetic Technologies Corporation (NASDAQ:AGTC): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 10:34 AMWill Applied Genetic Technologies Corporation (NASDAQ:AGTC) Surprise Analysts? - Investor Newswire
07/21/16 07:57 PMEquity Roundup: Stock Performance Focus on Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Press Telegraph
07/21/16 11:26 AMIncreased Stock Volatility Watch: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Engelwood Daily
07/21/16 11:26 AMBroker Outlook For Applied Genetic Technologies Corporation (AGTC) - Fiscal Standard
07/19/16 08:34 AMApplied Genetic Technologies Corporation (AGTC) Updated Price Targets - FTSE News
07/17/16 07:09 AMShares Moving Down on the Week: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Engelwood Daily
07/16/16 02:23 PMApplied Genetic Technologies Corporation (NASDAQ:AGTC) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/16/16 02:23 PMShares Experiencing a Downtrend: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - TGP
07/14/16 02:25 PMApplied Genetic Technologies Corporation Stock Momentum Hits Strength - CML News
07/14/16 02:25 PMEye on Stock Volatility for: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Engelwood Daily
07/13/16 03:34 PMAPPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers -
07/13/16 02:24 PMAre Analysts Bearish Applied Genetic Technologies Corp (NASDAQ:AGTC) After Last Week? - Press Telegraph
07/13/16 10:26 AMApplied Genetic Technologies Corporation (NASDAQ:AGTC) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 02:23 PMAPPLIED GENETIC TECHNOLOGIES CORP 2016 Q1 Institutional Investor Sentiment Better Than Expected - Press Telegraph
07/11/16 07:10 AMStock Rating Watch and Earnings Insight for Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Press Telegraph
07/08/16 10:24 AMCompany Stock Focus for Applied Genetic Technologies Corporation (NASDAQ:AGTC): Which Way Will Shares Head? - Press Telegraph
07/07/16 10:18 AMApplied Genetic Technologies Corp.: AGTC to Present at the Cantor Fitzgerald Second Annual Healthcare Conference ... - The Wall Street Transcript
07/07/16 06:11 AMAGTC to Present at the Cantor Fitzgerald Second Annual Healthcare Conference on July 13, 2016 - [at noodls] - GAINESVILLE, Fla., July 07, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies ...
07/06/16 07:08 AMApplied Genetic Technologies Corporation (NASDAQ:AGTC) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/04/16 02:21 PMBroker Outlook For The Week Ahead Applied Genetic Technologies Corporation (AGTC) - Fiscal Standard
07/02/16 10:03 AMApplied Genetic Technologies Corporation (AGTC) Jumps 5.94% on July 01 - Equities.com
07/01/16 02:21 PMWhat's in Applied Genetic Technologies Corp After Today's Huge Increase? - Engelwood Daily
06/30/16 02:26 PMApplied Genetic Technologies Corporation (AGTC) Jumps 6.03% on June 29 - Equities.com
06/29/16 07:31 PMShares Up in Session: Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Telanagana Press
06/29/16 02:21 PMApplied Genetic Technologies Corp Just Recorded A Sigfniciant Increase - Press Telegraph
06/29/16 02:21 PMApplied Genetic Technologies Corporation (NASDAQ:AGTC) Company Rating and Target Watch - Telanagana Press
06/29/16 02:21 PMHow Analysts Rated Applied Genetic Technologies Corp (NASDAQ:AGTC) Last Week? - Engelwood Daily
06/28/16 11:44 AM5 Best-Positioned Biotech Stocks on Brexit Volatility -
06/27/16 07:08 AMShare Update and Earnings Review for Applied Genetic Technologies Corporation (NASDAQ:AGTC) - Press Telegraph
06/27/16 07:08 AMApplied Genetic Technologies Corporation (AGTC) Broker Price Targets For The Coming Week - Fiscal Standard
06/24/16 02:21 PMApplied Genetic Technologies Corporation (NASDAQ:AGTC) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 02:21 PMCovering the Bases on Applied Genetic Technologies Corporation (NASDAQ:AGTC): Where is the Stock Going? - Press Telegraph
06/24/16 02:21 PMApplied Genetic Technologies Corporation (AGTC) is Trading Lower on Unusual Volume for June 22 - Equities.com
06/23/16 10:06 AMAchromatopsia - Pipeline Review, H1 2016 Featuring Amgen & Applied Genetic Technologies Corporation - Research and Markets
06/21/16 02:21 PMApplied Genetic Technologies Corporation (AGTC) Current Analyst Ratings - Fiscal Standard
06/19/16 07:07 AMApplied Genetic Technologies Corporation (AGTC) Analyst Price Targets For The Coming Week - Fiscal Standard
06/15/16 07:28 PMCan Applied Genetic Technologies Corporation (NASDAQ:AGTC) Meet Analysts Expectations? - Stocks Daily
06/09/16 08:17 PMAGTC to Host Research Day on June 21, 2016 in New York - GlobeNewswire (press release)
06/09/16 02:22 PMApplied Genetic Technologies Corp.: AGTC to Host Research Day on June 21, 2016 in New York - The Wall Street Transcript
06/09/16 11:15 AMAGTC to Host Research Day on June 21, 2016 in New York - Nasdaq
06/09/16 06:19 AMAGTC to Host Research Day on June 21, 2016 in New York - [at noodls] - GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 09, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated ...
06/08/16 02:49 PMAGTC receives orphan medicinal product designation for retinitis pigmentosa gene therapy in Europe
06/07/16 02:21 PMAGTC Announces Orphan Medicinal Product Designation in the European Union for Gene Therapy to Treat X-linked ... - GlobeNewswire (press release)
06/07/16 06:18 AMAGTC Announces Orphan Medicinal Product Designation in the European Union for Gene Therapy to Treat X-linked Retinitis Pigmentosa - [at noodls] - GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated ...
06/05/16 07:39 PMAfter Last Week What Do Analysts Think Of Applied Genetic Technologies Corporation (AGTC) - Share Trading News
06/03/16 10:51 AMShare Rating Focus on Applied Genetic Technologies Corporation (NASDAQ:AGTC) - HNN
06/02/16 08:22 PMStrong Sell Calls Count For Applied Genetic Technologies Corporation (NASDAQ:AGTC) At 0 - Investor Newswire - Strong Sell Calls Count For Applied Genetic Technologies Corporation (NASDAQ:AGTC) At 0Investor NewswireApplied Genetic Technologies Corporation (NASDAQ:AGTC) has a total of 7 Strong Buy calls and 0 Strong Sell advises as of 2016-06-01. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2 ...and more »
06/02/16 11:02 AMCould Applied Genetic Technologies Corp Gain Strenght? The Stock Reaches 52-Week Low - HNN - Could Applied Genetic Technologies Corp Gain Strenght? The Stock Reaches 52-Week LowHNNThe stock of Applied Genetic Technologies Corp (NASDAQ:AGTC) is a huge mover today! The stock decreased 3.37% or $0.58 during the last trading session, hitting $16.62. About 85,796 shares traded hands. Applied Genetic Technologies Corp ...

Social

About Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp. logoApplied Genetic Technologies Corp is a United States-based clinical stage biotechnology company. The Company develops gene therapy products for the treatment of inherited and acquired diseases. Its products are used to treat Alpha One Antitrypsin Deficiency (Alpha-1), a respiratory disease caused by deficiencies in the tissue protective protein alpha one antitrypsin; and Lebers congenital amaurosis, an inherited condition causing early blindness. Its products also used to treat X-linked retinoschisis, an inherited form of retinal degeneration affecting young males with poor vision either in infancy or at school age; and achromatopsia, an inherited condition that is associated with color blindness, visual acuity loss, and extreme light sensitivity resulting in daytime blindness.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AGTC
  • CUSIP:
Key Metrics:
  • Previous Close: $15.69
  • 50 Day Moving Average: $15.28
  • 200 Day Moving Average: $15.18
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $282.94M
  • Beta: 1.24
  • Current Year EPS Consensus Estimate: $-0.15 EPS
  • Next Year EPS Consensus Estimate: $-0.68 EPS
Additional Links:
Applied Genetic Technologies Corp. (NASDAQ:AGTC) Chart for Saturday, July, 23, 2016